FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating 68Ga-PSMA-PET imaging alongside MRI in the pre-biopsy prostate cancer setting.The designation recognizes the program ...

Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging. Melbourne (Australia) and Indianapolis, IN (United States) \| September 30, 2026. FDA Fast T ...

Medvue Concorde medical imaging clinic has become the first in Quebec to acquire the Siemens MAGNETOM Flow.Elite, a next-generation magnetic resonance imaging (MRI) system that integrates artificial ...

The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients.Telix has positively engaged with the FDA on a New ...

Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer).Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from ...

FEW days ago, a senior pastor of mine called and spoke fata-fata, as they say, about the state of our hospitals. His preambles were something else; it went something like this: Pastor Bolawole, I know ...

Altamuskin man Shane McCarney is living with stage four metastatic prostate cancer after years supporting cancer patients as a clinical psychologist.

[by Yu, Suin] “We expect revenue to more than double year-over-year in 2026 and aim to reach the break-even point (BEP) in ...

For a man facing a prostate biopsy, an MRI scan can give doctors a clearer idea of where to look for cancer before they ...

Using prostate MRI before a biopsy is a real advance in prostate cancer diagnosis. Multiple randomized trials have shown that ...

Although mpMRI can improve targeting of clinically significant prostate cancer, its performance depends in part on obtaining ...

Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.